Neonatal and pediatric ECMO with MiniLung petite kit
Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this…
Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this…
With immediate effect, Dr. Jürgen O. Böhm will take on the role of corporate management at Hemovent GmbH. As the new Chi…
Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congres…
Xenios AG, a Fresenius Medical Care company, has received approval from the National Medical Products Administration (NM…
The Management Board of Xenios AG, the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured. Effe…
As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be…
The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios…
Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019. Pr…
The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part o…
The results of the ECMO to rescue lung injury in severe ARDS (EOLIA) trial have long been awaited, since the first two t…